Effect of a Pre-operative Internet-based Educational Video on Post Operative Opioid Consumption
1 other identifier
interventional
220
1 country
1
Brief Summary
One of the most challenging issues in modern medicine is the current opioid epidemic. Given the association between opioid use after surgery and the development of opioid addiction, an essential goal of the medical community should be to develop strategies aimed at instructing the safe use of opioids. In addition, instructions on how to use non-opioid painkillers and exercises and techniques to better cope with pain can be used to reduce the patients opioid requirements after surgery. This study aims to evaluate the effect of providing an online educational video presentation to patients prior to surgery. This will be a 30 minute video which will provide the study participants with instructions on how best to use their opioid and non-opioid medication for pain and also teach the study participants exercises and techniques to better cope with their pain. This intervention will be used with a view to reduce the amount of opioids used by patients following hip or knee replacement surgery. Participants will be followed during their immediate phase after surgery to determine how much pain killers the participants have used and at six weeks the participants will be asked to return their unused opioids to see how much the participants have used in total.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2022
CompletedFirst Posted
Study publicly available on registry
January 21, 2022
CompletedStudy Start
First participant enrolled
September 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
March 12, 2026
March 1, 2026
3.7 years
January 7, 2022
March 10, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Post operative opioid consumption
Total opioid consumption during the first 72 hours following THA or TKA surgery, measured in oral morphine equivalents.
From surgery until 72 hours postoperatively.
Secondary Outcomes (10)
Postoperative Pain
On postoperative days 1/2/3, and 1- and 6-week follow-up.
Length of hospital stay
From day of admission until 72 hours postoperatively.
Time to first opioid demand dose
In the first 24 hours after surgery.
Post-operative complication rate
24 hours after surgery, and 1/6 week follow-ups.
Total opioid consumption at 6-week follow-up
6 weeks after surgery.
- +5 more secondary outcomes
Study Arms (2)
Opioid Counseling and PCS Video Group
EXPERIMENTALThis arm of the study will receive the opioid counseling and pain coping skills video 2 weeks prior to their surgery in addition to the conventional information provided to all patients undergoing total joint arthroplasty.
Standard of Care Group
NO INTERVENTIONThis arm of the study will the conventional information provided to all patients undergoing total joint arthroplasty.
Interventions
The intervention will be in the form of a video of a PowerPoint presentation with instructions and exercises designed to coach patients about catastrophizing, coping skills, mindfulness and behavioral modification techniques, in addition to providing education regarding postoperative analgesia and opioid use.
Eligibility Criteria
You may qualify if:
- Patients must be adults (\> 18 years of age) undergoing knee or hip arthroplasty.
- Patients will be ASA 1-3 undergoing elective surgery.
- English speaking patients with internet and computer access at home will be included.
- Patients with pre-existing psychological conditions who receive either pharmaceutical or talk-based therapy will be included.
You may not qualify if:
- Significant cognitive impairment.
- Chronic pain, long-term opioid therapy
- Renal replacement therapy
- Standing opioid requirements
- Neuropathic pain
- Fractures requiring emergency surgery
- End stage cardiac or respiratory disease
- Severe hepatic dysfunction,
- Patients with severe psychiatric disorders
- Vision loss
- Allergy to local anesthesia.
- Patients who refuse to consent to neuraxial anesthesia and/or peripheral nerve blocks will also be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 7, 2022
First Posted
January 21, 2022
Study Start
September 20, 2022
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
March 12, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share